Novelvi®
Noninvasive Prenatal Test (NIPT)
Noninvasive Prenatal Test (NIPT)
Novelvi® can be performed as soon as 10 weeks into pregnancy to evaluate the health of the developing fetus. The test screens for chromosomal abnormalities (aneuploidy) which can be associated with severe syndromes. Our Novelvi® panels use the latest sequencing technology to deliver extremely accurate results. Learn more about our two panels below.
Screens for the 3 most common aneuploidies:
Screens all 24 chromosomes for aneuploidy plus clinically relevant microdeletions. These include: